• The Food and Drug Administration (FDA) says abortion providers are prescribing abortion-inducing drugs to women in advance of becoming pregnant – a practice that is without authorization and potentially dangerous for women.
• The FDA is concerned that if patients were to take mifepristone weeks or months after getting a prescription filled, a medical professional may not be able to assess if a pregnancy is intrauterine or ectopic or date pregnancies properly. The drug is only approved through 70 days’ gestation for abortions.
• OB/GYN Dr. Christina Francis told The Star News Network the FDA’s reported concerns are exactly why she and other women’s physicians opposed the FDA’s decision to allow dispensing of the abortion-inducing drugs without an in-person visit.
• “While the FDA is rightly condemning the dangerous and untested practice of prescribing mifepristone and misoprostol to someone who isn’t even pregnant, it should be pointed out that the very dangers that the FDA official identifies in this interview – potentially missing an ectopic pregnancy or the chemical abortion drugs being used beyond 10 weeks’ gestation – are exactly the same when these dangerous drugs are dispensed without an in-person visit,” said Francis, a board member and CEO-elect of the American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG).

Tagged: Abortion